Effect of Sodium-Glucose Cotransporter 2 Inhibitors for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis of Randomized Clinical Trials-Reference-Cited by-同舟云学术

Effect of Sodium-Glucose Cotransporter 2 Inhibitors for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Published:2022-05-04 Issue: Volume:9 Page:
ISSN:2297-055X
Container-title:Frontiers in Cardiovascular Medicine
language:
Short-container-title:Front. Cardiovasc. Med.

Author:

Zhou Hufang,Peng Wenhua,Li Fuyao,Wang Yuelin,Wang Baofu,Ding Yukun,Lin Qian,Zhao Ying,Pan Guozhong,Wang Xian

Abstract

Graphical AbstractA systematic review and meta-analysis was performed to investigate the effect of sodium-glucose cotransporter 2 inhibitors for heart failure with preserved ejection fraction.

Funder

National Natural Science Foundation of China

Publisher

Frontiers Media SA

Subject

Cardiology and Cardiovascular Medicine

Reference90 articles.

1. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.;McDonagh;Eur Heart J.,2021

2. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals.;Conrad;Lancet.,2018

3. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes.;Steinberg;Circulation.,2012

4. Epidemiology of heart failure with preserved ejection fraction.;Dunlay;Nat Rev Cardiol.,2017

5. Heart failure with preserved ejection fraction in perspective.;Pfeffer;Circ Res.,2019

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of echocardiography compared to electrocardiogram when screening for left ventricular hypertrophy in hypertensive patients: A cross‐sectional study;The Journal of Clinical Hypertension;2024-07-04

2. Sodium–Glucose Transporter 2 Inhibitors in Heart Failure: An Overview of Systematic Reviews;Journal of Cardiovascular Development and Disease;2024-06-28

3. Efficacy and safety of sodium-glucose cotransporter-2 inhibitors for heart failure with mildly reduced or preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials;Frontiers in Cardiovascular Medicine;2023-10-12

4. SGLT2 inhibitors; suggested mechanism of actions in supporting post-myocardial infarction patients;Future Cardiology;2023-07

5. Efficacy and safety of sodium-glucose cotransporter-2 inhibitors in heart failure with mildly reduced or preserved ejection fraction: an overview of 36 systematic reviews;Heart Failure Reviews;2023-06-07